Completed PHASE4 INTERVENTIONAL NCT00199017

German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults

Multicenter Trial for Treatment Optimization in T-lymphoblastic Lymphoma in Adults and Adolescents Older Than 15 Years (GMALL T-LBL 1/2004) (Amend 1)

Sponsor: Johann Wolfgang Goethe University Hospital

Conditions Lymphoma, Lymphoblastic

Interventions Adriamycin Asparaginase CNS irradiation Cladribine Cyclophosphamide Cytarabine Daunorubicin Dexamethasone/Prednisolone G-CSF HDARAC Mediastinal irradiation Mercaptopurine Methotrexate Thioguanine VP16 Vincristine Vindesine

Updated 6 times since 2017 Last updated: Aug 20, 2010 Started: Apr 30, 2004 Primary completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Lymphoma, Lymphoblastic and is currently completed. Johann Wolfgang Goethe University Hospital leads this study, which shows 6 recorded versions since 2004 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johann Wolfgang Goethe University Hospital

Data source: Johann Wolfgang Goethe University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Frankfurt, Germany